» Articles » PMID: 31814991

Biofilms Facilitate Cheating and Social Exploitation of β-lactam Resistance in

Overview
Date 2019 Dec 10
PMID 31814991
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Gram-negative bacteria such as commonly resist β-lactam antibiotics using plasmid-encoded β-lactamase enzymes. Bacterial strains that express β-lactamases have been found to detoxify liquid cultures and thus to protect genetically susceptible strains, constituting a clear laboratory example of social protection. These results are not necessarily general; on solid media, for instance, the rapid bactericidal action of β-lactams largely prevents social protection. Here, we tested the hypothesis that the greater tolerance of biofilm bacteria for β-lactams would facilitate social interactions. We used a recently isolated strain, capable of strong biofilm formation, to compare how cooperation and exploitation in colony biofilms and broth culture drives the dynamics of a non-conjugative plasmid encoding a clinically important β-lactamase. Susceptible cells in biofilms were tolerant of ampicillin-high doses and several days of exposure were required to kill them. In support of our hypothesis, we found robust social protection of susceptible in biofilms, despite fine-scale physical separation of resistant and susceptible cells and lower rates of production of extracellular β-lactamase. In contrast, social interactions in broth were restricted to a relatively narrow range of ampicillin doses. Our results show that β-lactam selection pressure on Gram-negative biofilms leads to cooperative resistance characterized by a low equilibrium frequency of resistance plasmids, sufficient to protect all cells.

Citing Articles

Spatial population dynamics of bacterial colonies with social antibiotic resistance.

Denk-Lobnig M, Wood K Proc Natl Acad Sci U S A. 2025; 122(7):e2417065122.

PMID: 39937854 PMC: 11848446. DOI: 10.1073/pnas.2417065122.


Advancements in enzymatic reaction-mediated microbial transformation.

Zheng C, Gao L, Sun H, Zhao X, Gao Z, Liu J Heliyon. 2024; 10(19):e38187.

PMID: 39430465 PMC: 11489147. DOI: 10.1016/j.heliyon.2024.e38187.


A growth-coupling strategy for improving the stability of terpenoid bioproduction in Escherichia coli.

Tan J, Hu Q, Scrutton N Microb Cell Fact. 2024; 23(1):279.

PMID: 39415159 PMC: 11481808. DOI: 10.1186/s12934-024-02548-1.


Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams.

Goncalves Pereira J, Fernandes J, Mendes T, Gonzalez F, Fernandes S Antibiotics (Basel). 2024; 13(9).

PMID: 39335027 PMC: 11428226. DOI: 10.3390/antibiotics13090853.


When does antimicrobial resistance increase bacterial fitness? Effects of dosing, social interactions, and frequency dependence on the benefits of AmpC -lactamases in broth, biofilms, and a gut infection model.

Penkova E, Raymond B Evol Lett. 2024; 8(4):587-599.

PMID: 39100229 PMC: 11291625. DOI: 10.1093/evlett/qrae015.


References
1.
Kim S, Park S, Im S, Lee J, Jung J, Gong T . Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics. Sci Rep. 2018; 8(1):5402. PMC: 5876404. DOI: 10.1038/s41598-018-23656-0. View

2.
Tamma P, Fan Y, Bergman Y, Pertea G, Kazmi A, Lewis S . Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates. Antimicrob Agents Chemother. 2018; 63(1). PMC: 6325187. DOI: 10.1128/AAC.01923-18. View

3.
Lenski R, Hattingh S . Coexistence of two competitors on one resource and one inhibitor: a chemostat model based on bacteria and antibiotics. J Theor Biol. 1986; 122(1):83-93. DOI: 10.1016/s0022-5193(86)80226-0. View

4.
Anderl J, Franklin M, Stewart P . Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2000; 44(7):1818-24. PMC: 89967. DOI: 10.1128/AAC.44.7.1818-1824.2000. View

5.
Dugatkin L, Perlin M, Lucas J, Atlas R . Group-beneficial traits, frequency-dependent selection and genotypic diversity: an antibiotic resistance paradigm. Proc Biol Sci. 2005; 272(1558):79-83. PMC: 1634946. DOI: 10.1098/rspb.2004.2916. View